Overview

Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes

Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy and safety of Haporine-S eye drop for the patients with moderate to severe dry eye disease in a multicenter phase III clinical trial.
Phase:
Phase 3
Details
Lead Sponsor:
DH Bio Co., Ltd.
Collaborator:
BTO Pharm. Co., Ltd.
Treatments:
Cyclosporine
Cyclosporins